You have no items in your shopping cart.
Search results for: 'HEK293'
> 90% as determined by SDS-PAGE
45.6 kDa
100 μg, 500 μg> 95% as determined by Tris-Bis PAGE
10 μg- RecombinantVEGF-C,Human [orb1494619]
> 95% as analyzed by SDS-PAGE.
16~19 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg > 95% as analyzed by SDS-PAGE.
20~26 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg> 95% as analyzed by SDS-PAGE.
10~20 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg> 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg> 95% as analyzed by SDS-PAGE and HPLC.
10-40 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg> 98% as analyzed by SDS-PAGE.
8.2 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg- RecombinantMCP-1/CCL2,Rat [orb1494632]
> 98% as analyzed by SDS-PAGE.
10~15 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg > 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg, 1 mg
